BIOASIS TECHNOLOGIES INC (BTI.CA) Stock Price, Quote, News and Overview
TSX-V:BTI - TSX Venture Exchange - CA09064N1033 - Common Stock - Currency: CAD
BTI.CA Quote, Performance and Key Statistics
TSX-V:BTI (3/18/2024, 7:00:00 PM)
0.005
0 (0%)
The current stock price of BTI.CA is 0.005 CAD. In the past year, price decreased by -92.31%.
BTI.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 250.91M | ||
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 249.50M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 193.59M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 165.99M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 82.91M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 15.47 | 72.11M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 66.23M | ||
| BLU.CA | BLUENERGIES LTD | N/A | 58.33M | ||
| ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 56.81M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 51.14M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 50.90M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | 36 | 50.77M |
Related stock screener links
About BTI.CA
Company Profile
biOasis Technologies, Inc. operates as a biopharmaceutical company. The company is headquartered in Burnaby, British Columbia. The company went IPO on 2007-07-24. The firm is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). The company is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The firm is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.
Company Info
BIOASIS TECHNOLOGIES INC
22420 Dewdney Trunk Road, Suite 300
Burnaby BRITISH COLUMBIA 06437 CA
CEO: Deborah Ann Rathjen
Employees: 0
Phone: 12035337082
BIOASIS TECHNOLOGIES INC / BTI.CA FAQ
What is the stock price of BIOASIS TECHNOLOGIES INC today?
The current stock price of BTI.CA is 0.005 CAD.
What is the ticker symbol for BIOASIS TECHNOLOGIES INC stock?
The exchange symbol of BIOASIS TECHNOLOGIES INC is BTI and it is listed on the TSX Venture Exchange exchange.
On which exchange is BTI.CA stock listed?
BTI.CA stock is listed on the TSX Venture Exchange exchange.
What is BIOASIS TECHNOLOGIES INC worth?
BIOASIS TECHNOLOGIES INC (BTI.CA) has a market capitalization of 397.07K CAD. This makes BTI.CA a Nano Cap stock.
How many employees does BIOASIS TECHNOLOGIES INC have?
BIOASIS TECHNOLOGIES INC (BTI.CA) currently has 0 employees.
What are the support and resistance levels for BIOASIS TECHNOLOGIES INC (BTI.CA) stock?
BIOASIS TECHNOLOGIES INC (BTI.CA) has a resistance level at 0.01. Check the full technical report for a detailed analysis of BTI.CA support and resistance levels.
Is BIOASIS TECHNOLOGIES INC (BTI.CA) expected to grow?
The Revenue of BIOASIS TECHNOLOGIES INC (BTI.CA) is expected to grow by 215.79% in the next year. Check the estimates tab for more information on the BTI.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BIOASIS TECHNOLOGIES INC (BTI.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BTI.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BTI.CA, evaluating the profitability, health, valuation and growth aspects
- BIOASIS TECHNOLOGIES INC (BTI.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIOASIS TECHNOLOGIES INC (BTI.CA) Sales and EPS estimates to see what analysts future expectations are.
- BIOASIS TECHNOLOGIES INC (BTI.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIOASIS TECHNOLOGIES INC (BTI.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIOASIS TECHNOLOGIES INC (BTI.CA) Stock Chart to make your own analysis
- BIOASIS TECHNOLOGIES INC (BTI.CA) Latest news and press-releases to stay up to date.
Does BIOASIS TECHNOLOGIES INC (BTI.CA) stock pay dividends?
BTI.CA does not pay a dividend.
When does BIOASIS TECHNOLOGIES INC (BTI.CA) report earnings?
BIOASIS TECHNOLOGIES INC (BTI.CA) will report earnings on 2022-01-26.
What is the Price/Earnings (PE) ratio of BIOASIS TECHNOLOGIES INC (BTI.CA)?
BIOASIS TECHNOLOGIES INC (BTI.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.04).
BTI.CA Technical Analysis
BTI.CA Financial Highlights
Over the last trailing twelve months BTI.CA reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS increased by 21.43% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -163.11% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
BTI.CA Ownership and Analysts
For the next year, analysts expect an EPS growth of -16.67% and a revenue growth 215.79% for BTI.CA